Home > Boards > US OTC > Biotechs > OncoSec Medical Inc. (ONCS)

Everyone should also look at TTNP... possible priority

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
interstate Member Profile
 
Followed By 14
Posts 3,974
Boards Moderated 0
Alias Born 02/23/09
160x600 placeholder
Analysts Are Bullish on Top Healthcare Stocks: Immunic (IMUX), OncoSec Medical (ONCS) TipRanks - 12/16/2021 9:15:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2021 4:31:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/30/2021 4:16:18 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/16/2021 6:08:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 8:01:34 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/8/2021 6:02:42 AM
Annual Report (10-k) Edgar (US Regulatory) - 10/29/2021 3:58:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:47:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:44:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:43:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:42:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:40:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:39:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:39:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:38:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:37:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:36:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2021 4:56:00 PM
OncoSec names Brian Leuthner as interim chief executive officer Seeking Alpha - 6/24/2021 4:34:03 PM
OncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey Silverman, as Vice President of Product Engineering PR Newswire (US) - 6/14/2021 8:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/11/2021 5:13:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/11/2021 5:02:50 PM
OncoSec to Present at the Raymond James Human Health Innovation Conference PR Newswire (US) - 5/27/2021 8:30:00 AM
OncoSec Appoints Robert M. Schinagl, Ph.D. as Vice President of Program and Alliance Management PR Newswire (US) - 5/17/2021 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/26/2021 2:12:52 PM
interstate   Thursday, 11/15/12 01:11:33 PM
Re: None
Post # of 48149 
Everyone should also look at TTNP... possible priority track for their NDA FDA approval and partner by end of year. Look at the most recent seeking alpha article from their conference call transcript.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences